New cancer drug begins early human testing
Disease control
Recruiting now
This is an early-stage study to test the safety and find the right dose of a new drug called ACR246 for people with advanced solid tumors. It will involve about 77 adults whose cancer has continued to grow despite standard treatments. The main goal is to see how well the drug is …
Phase: PHASE1 • Sponsor: Hangzhou Adcoris Biopharmacy Co., Ltd • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC